Source: Bloomberg BusinessWeek
By: Mildenberg, David
The U.S. Department of Health and Human Services has approved a GlaxoSmithKline plan to build a $91 million flu vaccine plant northwest of Houston in the College Station area. The facility will enable the government to respond quickly with vaccines or treatments in the event of an influenza pandemic or biological attack, according to a joint statement from GSK and the Texas A&M University System. The plant will be capable of supplying 50 million doses of influenza vaccine within four months of an outbreak. The project is an “unprecedented public-private collaboration to protect against pandemics and bio-threats,” said Antoon Loomans, senior vice president of GSK Vaccines.